Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Parallel has appointed Jeremy Kunicki, a former executive at Walgreens Boots Alliance (NASDAQ: WBA), as its new Chief Financial Officer effective immediately. This transition coincides with Parallel's plans to go public through a business combination with Ceres Acquisition Corp. Kunicki, with two decades of experience at Walgreens, will oversee finance and operations as Parallel aims to expand as a national cannabis company. His background in finance, coupled with a focus on consumer health, is expected to strengthen Parallel’s growth trajectory.
Walgreens has partnered with Labcorp to sell the Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter at 6,000 stores nationwide. Starting spring 2021, this will be Walgreens' first in-store testing option, enhancing access in underserved areas. Walgreens aims to increase its on-site testing capacity to over 5,000 locations by April 1. The kits allow customers to self-administer tests and send samples to Labcorp for processing. Test results will be available online, with follow-up by healthcare professionals for positive results.
On February 24, 2021, Clinical Reference Laboratory (CRL) partnered with Walgreens to launch the FDA-authorized Rapid Response COVID-19 Saliva Test via Walgreens Find Care. This non-invasive test allows users to self-collect samples at home, boasting 100% sensitivity and specificity. Priced at $119, results are typically available within 24-48 hours. Walgreens aims to enhance access to COVID-19 testing, integrating it into their digital health platform. CRL has distributed over 500,000 tests, affirming its commitment to convenient and reliable testing solutions.
Walgreens is expanding its on-demand delivery services in collaboration with Instacart, starting in Illinois and set to roll out nationwide to nearly 8,000 stores. Customers can order a wide range of products, including health and wellness items, for same-day delivery in as fast as one hour. The service will also extend to major markets like Southeast Florida, Dallas, and New York City. This initiative is part of Walgreens' digital transformation efforts aimed at enhancing customer convenience amidst changing consumer needs.
Walgreens has administered over 3 million COVID-19 vaccinations in long-term care facilities and aims to expand access through the Federal Retail Pharmacy Program, starting February 12. The company is set to receive over 480,000 vaccine doses weekly, supporting immunization efforts in various states. Walgreens also launched a Vaccine Equity Initiative to enhance access in underserved communities through partnerships and educational programs. The initiative includes off-site vaccination clinics and collaborations aimed at addressing vaccine hesitancy and transportation barriers.
Walgreens has administered over 3 million COVID-19 vaccinations in long-term care facilities and vulnerable populations. The company completed first-dose clinics in all participating facilities and began in-store vaccinations on Feb. 12, quickly administering nearly 180,000 doses within three days. Starting Feb. 25, Walgreens will receive over 480,000 weekly doses in multiple states. The company is launching the Vaccine Equity Initiative to improve access and address vaccine hesitancy, hosting clinics in underserved communities and partnering with organizations for education and transportation support.
Walgreens has expanded its Expressions Challenge program nationally, encouraging teens to express themselves through creative arts. This year's contest runs until March 31, 2021, with $2,000 awarded to 12 winners across three categories: visual arts, video production, and spoken word. A Specialty Award will also be given to the best submission addressing COVID-19, with a prize of $1,000. Since 2009, Walgreens has awarded over $350,000 and reached over one million students, supporting youth empowerment during challenging times.
Walgreens Boots Alliance (Nasdaq: WBA) launched its 2020 Corporate Social Responsibility (CSR) Report, highlighting its community-driven initiatives in healthcare access, diversity, and sustainability. Key achievements include COVID-19 testing in underserved areas, providing over 250 million vitamins and 60 million vaccines globally, and reducing its carbon footprint. The company emphasizes its role as a responsible corporate citizen during the pandemic and is hosting a virtual event featuring industry leaders to discuss pressing health issues.
Walgreens and Uber Technologies, Inc. (NYSE: UBER) have partnered to enhance access to COVID-19 vaccines for underserved communities. This collaboration aims to tackle barriers to health equity, including education and transportation. Key initiatives include providing free transportation to vaccine sites, facilitating ride scheduling through Uber, and launching educational programs to combat vaccine hesitancy. Uber has committed to offering up to 10 million free or discounted rides, while Walgreens expands its services in socially vulnerable areas. This partnership seeks to ensure equitable vaccine distribution as availability increases.
Walgreens has been selected by the CDC and U.S. Department of Health and Human Services to administer COVID-19 vaccinations in 15 states starting February 12. Eligible individuals include healthcare workers, seniors, and those with pre-existing conditions. Walgreens aims to optimize vaccine access in underserved areas, having already provided nearly two million vaccinations. The company will manage limited vaccine inventory by appointment only, and it has also supported long-term care facility vaccinations, completing first doses in over 75% of selected facilities.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
